| CA9 | carbonic anhydrase 9 |
| CLM | colorectal liver metastasis |
| CMS | consensus molecular subtype |
| CRC | colorectal cancer |
| CRT | chemoradiotherapy |
| dMMR | deficient MMR function |
| FLT3LG | fms-related tyrosine kinase 3 ligand |
| HAI | hepatic artery infusion |
| HMGB1 | high-mobility group box-1 |
| ICB | immune checkpoint blockade |
| ICD | immunogenic cell death |
| LARC | locally advanced rectal cancer |
| MDSC | myeloid-derived suppressor cells |
| MMP9 | matrix metallopeptidase 9 |
| MMR | DNA mismatch-repair |
| MSI | microsatellite-instable |
| NACT | neoadjuvant chemotherapy |
| OPG | osteoprotegerin |
| OS | overall survival |
| PD-1 | programmed death receptor 1 |
| PD-L1 | PD-1 ligand |
| pMMR | proficient MMR function |
| PFS | progression-free survival |
| TME | tumor microenvironment |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.